NDC 79903-032-01 - EXTRA STRENGTH ACETAMINOPHEN

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
79903-032
Requested NDC
79903-032-01
Package NDCs from labels
79903-032-01, 79903-032-02, 79903-032-40, 79903-032-10
Manufacturer
Wal-Mart Stores Inc
Effective date
2026-01-27
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
EXTRA STRENGTH ACETAMINOPHEN - Wal-Mart Stores IncWal-Mart Stores Inc2026-01-27HUMAN OTC DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
79903-032-01EXTRA STRENGTH ACETAMINOPHEN100 in 1 BOTTLETABLET1009
79903-032-02EXTRA STRENGTH ACETAMINOPHEN2 in 1 CARTONTABLET29
79903-032-10EXTRA STRENGTH ACETAMINOPHEN100 in 1 BOTTLETABLET1009
79903-032-40EXTRA STRENGTH ACETAMINOPHEN1 in 1 CARTONTABLET19
79903-032-40EXTRA STRENGTH ACETAMINOPHEN40 in 1 BOTTLETABLET409

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
79903-032EXTRA STRENGTH ACETAMINOPHEN (ACETAMINOPHEN) TABLET [WAL-MART STORES INC]7Current NDC, Legacy NDC, 5 package rows20250101_a88eba4c-0701-4eec-9a24-a804186fbfd8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
79903-032-02EA - Each79903-032a10a10d5-5af2-4301-8812-8416ef5a93c112023-09-05
79903-032-10EA - Each79903-032efb4f630-797b-4a17-94d1-02abfd986a3512022-12-07
79903-032-40EA - Each79903-0324422bb8e-0e56-4f3a-af3e-a7762b7f005012022-12-07

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 231 of 275 · 5,498 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BUTALBITAL, ACETAMINOPHEN AND CAFFEINEBUTALBITAL, ACETAMINOPHEN AND CAFFEINEQUAGEN PHARMACEUTICALS LLC8438f08f-a32a-4180-9030-e0fd5da4be302024-05-07Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 362O9ITL9D
basic care childrens pain and feverACETAMINOPHENAmazon.com Services LLC790d8883-52be-46f2-9838-564b6c5d57f92024-05-07WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Rugby Childrens AcetaminophenACETAMINOPHENRugby Laboratories304a9aa2-9198-44ca-8627-d41b84ec6cbf2024-05-07WarningsExact identifier
application number: M013
unii: 362O9ITL9D
careone childrens acetaminophenACETAMINOPHENAmerican Sales Company808f4790-cadd-4285-ae70-25eb547137e22024-05-07WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Severe Cold and Flu Nighttime HoneyACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCLKroger10b12f0e-dba7-fd71-e063-6294a90a42c12024-05-06WarningsExact identifier
unii: 362O9ITL9D
BUTALBITAL and ACETAMINOPHENBUTALBITAL AND ACETAMINOPHENQUAGEN PHARMACEUTICALS LLC1f0dbe62-6aea-4323-ad25-c2211f9192532024-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 362O9ITL9D
BUTALBITAL, ACETAMINOPHEN AND CAFFEINEBUTALBITAL, ACETAMINOPHEN AND CAFFEINEQUAGEN PHARMACEUTICALS LLC24813ec6-0111-4782-9182-a2b93501a2bc2024-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 362O9ITL9D
AcetaminophenACETAMINOPHENBaxter Healthcare Corporation0f67c1bd-915b-4681-88dd-22f5154a80b32024-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 362O9ITL9D
Basic Care Childrens Pain and FeverACETAMINOPHENAmazon.com Services LLCbf8bed5d-7dd4-492c-98ac-c36ff8be8f412024-05-06WarningsExact identifier
application number: M013
unii: 362O9ITL9D
Basic Care Childrens Pain and FeverACETAMINOPHENAmazon.com Services LLC0c133707-a8b8-4105-82f3-e3855ec196172024-05-06WarningsExact identifier
application number: M013
unii: 362O9ITL9D
leader infants pain and feverACETAMINOPHENCardinal Health 110, LLC. dba Leadercfbb8553-f3ac-437d-8f63-caa93f257a772024-05-06WarningsExact identifier
application number: M013
unii: 362O9ITL9D
LOW DOSE ASPIRINASPIRINBryant Ranch Prepacka272bf44-54df-448a-8bff-e31f9488b4162024-05-06WarningsExact identifier
application number: M013
BUTALBITAL and ACETAMINOPHENBUTALBITAL AND ACETAMINOPHENQUAGEN PHARMACEUTICALS LLC2eb09253-7f59-401e-afbc-70bb9600fedf2024-05-06Boxed warning, Warnings, Adverse reactionsExact identifier
unii: 362O9ITL9D
good sense childrens pain and feverACETAMINOPHENL. Perrigo Companyab96395c-a19e-40d6-b37e-7f988026fc952024-05-06WarningsExact identifier
application number: M013
unii: 362O9ITL9D
AcetaminophenACETAMINOPHENWALGREEN CO.c20d110a-ed5e-aed4-e053-2a95a90a42002024-05-06WarningsExact identifier
unii: 362O9ITL9D
Daytime Cold and FluACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLKroger1014da86-3a0e-136f-e063-6294a90ac9312024-05-04WarningsExact identifier
unii: 362O9ITL9D
Theraflu-D Flu Relief Max Strength plus Nasal DecongestantACETAMINOPHEN, DEXTROMETHORPHAN HBR, PSEUDOEPHEDRINE HCLHaleon US Holdings LLCe35cb719-9e7d-4b2b-81a4-29e147dd74fa2024-05-03WarningsExact identifier
unii: 362O9ITL9D
Theraflu-D Flu Relief Max Strength plus Nasal Decongestant NighttimeACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HBR, PSEUDOEPHEDRINE HCLHaleon US Holdings LLC09e20842-2b75-43b9-ae5f-3515b35e655b2024-05-03WarningsExact identifier
unii: 362O9ITL9D
Cold and Flu ReliefACETAMINOPHEN DEXTROMETHORPHAN HBR PHENYLEPHRINE HCLFamily Dollar (FAMILY WELLNESS)f958d8ba-ede9-4b1a-8317-2404b68a91292024-05-03WarningsExact identifier
unii: 362O9ITL9D
Night Time Cold and Flu Relief Multi SymptomACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEQUALITY CHOICE (Chain Drug Marketing Association)07c7c0d9-f063-4efc-8a08-2a1bfa9ca84a2024-05-01WarningsExact identifier
unii: 362O9ITL9D

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.